Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Ra'Anana
- Most recent report
- 10-Q, filed Nov 4, 2026
- Incorporated
- N/A
- Filings on record
- 583 filings
- On EDGAR
- CIK 1668243
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 63
News 8 of 85
Prospectuses and Registrations 8 of 29
- S-8 Registration statement for an employee plan Nov 4, 2026
- S-8 Registration statement for an employee plan Nov 6, 2025
- S-3ASR Automatic shelf registration Nov 6, 2025
- S-8 Registration statement for an employee plan Aug 13, 2024
- 424B5 Prospectus supplement for an offering Jun 18, 2024
- 424B5 Prospectus supplement for an offering Jun 17, 2024
- S-8 Registration statement for an employee plan Nov 14, 2023
- S-3 Shelf registration statement Sep 8, 2023
Proxies 8 of 15
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2026
- PRE 14A Preliminary proxy statement Apr 17, 2026
- DEF 14A Proxy statement for a shareholder vote Jul 15, 2025
- DEFA14A Extra proxy material Jul 1, 2024
- DEF 14A Proxy statement for a shareholder vote Jul 1, 2024
- DEFA14A Extra proxy material Aug 1, 2023
- DEF 14A Proxy statement for a shareholder vote Aug 1, 2023
- DEFA14A Extra proxy material May 17, 2022
Ownership 8 of 336
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 27, 2026
- 4 Insider reported a trade Oct 9, 2026
- 144 Notice of a proposed sale of restricted stock Oct 9, 2026
- 4 Insider reported a trade Sep 9, 2026
- 4 Insider reported a trade Sep 9, 2026
- 144 Notice of a proposed sale of restricted stock Sep 9, 2026
- 144 Notice of a proposed sale of restricted stock Sep 9, 2026
- 4 Insider reported a trade Aug 28, 2026
Other 8 of 55
- ARS Annual report sent to shareholders May 27, 2026
- ARS Annual report sent to shareholders Jul 16, 2025
- ARS Annual report sent to shareholders Jul 9, 2024
- UPLOAD Comment letter from SEC staff Dec 5, 2023
- CORRESP Reply to SEC staff Nov 27, 2023
- UPLOAD Comment letter from SEC staff Nov 16, 2023
- EFFECT Notice that a registration became effective Sep 15, 2023
- CORRESP Reply to SEC staff Sep 13, 2023
Everything here comes from UroGen Pharma Ltd.'s own filings on SEC EDGAR. The filing list is rechecked every hour.